This suggests that cAMP analogs could be particularly beneficial in conditions where mechanotransduction is dysfunctional or impaired, such as in certain forms of vascular disease or genetic disorders affecting Piezo1 signaling. The gene discussed is PIEZO1; the disease is hereditary disease.